Jin, Q., Zheng, J., Chen, M., Jiang, N., Xu, X., & Huang, F. (2021). HIF-1 Inhibitor YC-1 Reverses the Acquired Resistance of EGFR-Mutant HCC827 Cell Line with MET Amplification to Gefitinib. Oxid Med Cell Longev.
Παραπομπή Chicago StyleJin, Qian, Jisheng Zheng, Ming Chen, Na Jiang, Xianrong Xu, και Feihua Huang. "HIF-1 Inhibitor YC-1 Reverses the Acquired Resistance of EGFR-Mutant HCC827 Cell Line With MET Amplification to Gefitinib." Oxid Med Cell Longev 2021.
Παραπομπή MLAJin, Qian, et al. "HIF-1 Inhibitor YC-1 Reverses the Acquired Resistance of EGFR-Mutant HCC827 Cell Line With MET Amplification to Gefitinib." Oxid Med Cell Longev 2021.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.